Disphanurat, W. and Srisantithum, B. 2022. Efficacy and Safety of 0.15% Isobutylamido Thiazolyl Resorcinol Combined with Hyaluronic Acid versus 0.15% Isobutylamido Thiazolyl Resorcinol or Hyaluronic Acid Alone in Melasma Treatment: A randomized Evaluator-blind Trial. Asian Medical Journal and Alternative Medicine. 22, - (Aug. 2022), S117. DOI:https://doi.org/10.14456/2022s10724.